Chemfab Alkalis Ltd. AI Stock Analysis
Want to see IN:CHEMFAB full AI Analyst Report?
Chemfab Alkalis Ltd. (CHEMFAB) AI Stock Analysis
Chemfab Alkalis Ltd.
(NSE:CHEMFAB)
Primarily impacted by weak financial performance from revenue declines and losses, along with poor valuation due to negative earnings. Neutral technical signals provide limited offset.
Chemfab Alkalis Ltd. (CHEMFAB) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 4.60B
- Dividend Yield
- 0.39%
- Average Volume (3M)
- 275
- Price to Earnings (P/E)
- -1372.2
- Beta (1Y)
- 1.14
- Revenue Growth
- -15.22%
- EPS Growth
- 94.97%
- Country
- India
- Employees
- 219
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Chemfab Alkalis Ltd. Business Overview & Revenue Model
Company Description
Established in 1985 and headquartered in Chennai, India, Chemfab Alkalis Limited is an international manufacturer and vendor of inorganic chemical products. The company's business activities are structured around two main segments: Chemicals and Rela...
How the Company Makes Money
null
Chemfab Alkalis Ltd. Financial Statement Overview
Summary
Mixed results with strong historical revenue growth but recent declines, net losses, rising debt offset by equity growth and positive operating cash flows.
Income Statement
35NegativeBalance Sheet
55NeutralCash Flow
45Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.92B | 3.11B | 3.34B | 3.27B | 3.31B | 2.71B |
| Gross Profit | 309.00M | 410.05M | 1.16B | 573.09M | 1.57B | 972.61M |
| EBITDA | 331.89M | 359.06M | 444.34M | 632.53M | 1.13B | 624.45M |
| Net Income | -3.41M | -34.27M | -69.40M | 263.23M | 645.83M | 287.47M |
Balance Sheet | ||||||
| Total Assets | 5.82B | 5.77B | 5.22B | 5.00B | 4.12B | 3.52B |
| Cash, Cash Equivalents and Short-Term Investments | 9.54M | 143.98M | 211.84M | 76.98M | 692.16M | 328.37M |
| Total Debt | 1.44B | 1.26B | 843.41M | 201.11M | 23.57M | 86.47M |
| Total Liabilities | 2.05B | 2.01B | 1.42B | 1.13B | 507.42M | 541.82M |
| Stockholders Equity | 3.78B | 3.75B | 3.80B | 3.87B | 3.61B | 2.98B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -603.87M | 399.09M | -605.69M | 349.82M | 347.13M |
| Operating Cash Flow | 0 | 308.32M | 399.09M | 313.54M | 925.95M | 549.10M |
| Investing Cash Flow | 0 | -808.36M | -859.86M | -1.10B | -475.12M | -210.25M |
| Financing Cash Flow | 0 | 380.62M | 587.23M | 160.65M | -88.92M | -245.73M |
Chemfab Alkalis Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CHEMFAB, the sentiment is Neutral. The current price of 319.00 is above the 20-day moving average (MA) of 309.74, below the 50-day MA of 334.87, and below the 200-day MA of 370.40, indicating a neutral trend. The MACD of -8.06 indicates Negative momentum. The RSI at 51.53 is Neutral, neither overbought nor oversold. The STOCH value of 55.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:CHEMFAB.
Chemfab Alkalis Ltd. Peers Comparison
Overall Rating
IN:VISHNU69Neutral
IN:AARTISURF66Neutral
IN:ALKALI63Neutral
IN:CHEMBOND61Neutral
IN:SUKHJITS52Neutral- IN:CHEMFAB44Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| IN:VISHNU | 69Neutral | INR 37.49B | 24.23 | ― | 0.05% | 14.06% | 9.32% |
| IN:AARTISURF | 66Neutral | INR 4.41B | 24.39 | ― | 0.19% | 25.22% | 20.38% |
| IN:ALKALI | 63Neutral | INR 806.15M | 31.37 | ― | 1.24% | 13.73% | ― |
| IN:CHEMBOND | 61Neutral | INR 2.75B | 17.57 | ― | 1.00% | 0.83% | -34.03% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| IN:SUKHJITS | 52Neutral | INR 4.75B | 10.73 | ― | 0.64% | 9.42% | 97.19% |
| IN:CHEMFAB | 44Neutral | INR 4.59B | -1372.17 | ― | 0.39% | -15.22% | 94.97% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:CHEMFAB | Chemfab Alkalis Ltd. | 319.00 | -200.46 | -38.59% | |
| IN:AARTISURF | Aarti Surfactants Ltd. | 528.30 | 79.47 | 17.71% | |
| IN:ALKALI | Alkali Metals Ltd. | 82.00 | -2.07 | -2.46% | |
| IN:CHEMBOND | Chembond Chemicals Limited | 197.45 | 28.29 | 16.72% | |
| IN:SUKHJITS | Sukhjit Starch & Chemicals Ltd. | 155.90 | 1.99 | 1.29% | |
| IN:VISHNU | Vishnu Chemicals Limited | 548.75 | 60.38 | 12.36% |
Chemfab Alkalis Ltd. Corporate Events
Chemfab Alkalis Corrects AGM Notice, Confirms Dividend and Governance Items
Chemfab Alkalis Limited has issued a corrigendum to its previously circulated notice for the 17th Annual General Meeting, correcting typographical errors in the serial numbering of special business agenda items. The revised numbering clarifies that r...
Chemfab Alkalis Schedules Virtual 17th AGM for September 2026
Chemfab Alkalis Ltd. has announced that its 17th Annual General Meeting will be held on 9 September 2026 via video conferencing and other audio-visual means, enabling shareholders to participate remotely. This format aligns with evolving corporate go...
Chemfab Alkalis moves AGM online and urges investors to update KYC, access FY26 report via web link
Chemfab Alkalis Ltd. has notified the stock exchanges that it has sent letters to shareholders whose email addresses are not registered, providing a web link to access the company’s Annual Report for FY 2025-26. This move ensures regulatory complianc...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 18, 2026